The University of Alabama at Birmingham is partnering with biopharmaceutical company Altimmune Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease. The testing at UAB will investigate immune responses to the vaccine in mice, a key step before the Maryland-based Altimmune can launch a phase 1 human safety and immunogenicity trial in…
